High Tide Inc. HITI
Free
No email, no account, no signup.
General analysis — not personal advice.
Bull
Bear
Want to follow High Tide Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Exchange
NASDAQ
Type
Retail
Sector
Cannabis retail and medical distribution
Price & valuation
Last close
USD 2.34
1 week
+3.1 %
3 months
-2.9 %
12 months
-0.8 %
From 52w high
-41.2 %
From 52w low
+14.1 %
We're already tracking High Tide Inc. — here are the latest events we've registered
Recent News
- On August 4, 2026, High Tide issued preliminary guidance for its third fiscal quarter ended July 31, 2026, projecting revenue between C$195.0 million and C$200.0 million. The company also announced that its German subsidiary, Remexian Pharma GmbH, distributed over 10 tonnes of medical cannabis flower during the quarter. Full Q3 results are scheduled to be released on September 14, 2026.
What Firelda Watch includes for High Tide Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — AI roundup of the week's news
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of High Tide Inc. will be delivered in the same format.
Want to follow High Tide Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow 3 companies freeEmail when the signal or risk changes · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.